<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01647568</url>
  </required_header>
  <id_info>
    <org_study_id>DVAMC-09-084</org_study_id>
    <nct_id>NCT01647568</nct_id>
  </id_info>
  <brief_title>Safety of Continuing Anti-platelet Agents During Colonoscopic Polypectomy: A Prospective Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dallas VA Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dallas VA Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      At our VA hospital, in general, it is the policy of our GI lab to not stop our patients
      anti-platelet therapy whenever they see us for a routine colonoscopy. We do this because we
      believe the risk of stopping these sort of medications outweigh the risks of a complication
      from a colonoscopy.

      Therefore, we are enrolling patients who are either on clopidogrel or prasugrel or not on any
      anti-platelet/anti-coagulant therapy that come to our GI lab routine colonoscopies. We
      perform the procedure just like we normally would and then follow-up with the patient 7 and
      30 days after their procedure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">715</enrollment>
  <condition>Post-polypectomy Bleeding</condition>
  <condition>Anti-platelet Therapy</condition>
  <condition>Colonoscopy</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Patients who are not on any anti-platelet/anti-coagulant therapy and present to our lab for a elective colonoscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Thienopyridine Users</arm_group_label>
    <description>Patients on Clopidogrel or prasugrel when they present for an elective colonoscopy.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting to the GI lab for elective colonoscopy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients presenting to the GI lab for elective colonoscopy

        Exclusion Criteria:

          -  Patients on Coumadin or other anti-coagulants

          -  Patients with Inflammatory Bowel Disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Dallas VA Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 19, 2012</study_first_submitted>
  <study_first_submitted_qc>July 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2012</study_first_posted>
  <last_update_submitted>July 19, 2012</last_update_submitted>
  <last_update_submitted_qc>July 19, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 23, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dallas VA Medical Center</investigator_affiliation>
    <investigator_full_name>Linda A Feagins</investigator_full_name>
    <investigator_title>Staff Gastroenterologist</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

